Informed Consent Issues Proving Tricky In CMS Evidence-Development Policy
This article was originally published in The Gray Sheet
Executive Summary
Issues surrounding informed consent appear to be complicating CMS' efforts to finalize a policy allowing it to require evidence collection as a condition of national Medicare coverage
You may also be interested in...
Informed Consent Debate Resurfaces Over Medicare Coverage With Evidence Development
The debate over whether informed consent is necessary and whether it can be valid in the context of Medicare coverage-with-evidence-development determinations came up in public comments to CMS on its pending national coverage policy for transcatheter aortic valve replacement.
CMS Offers Two Paths To “Coverage With Evidence” In Revised Guidance
CMS introduces two distinct categories of coverage-with-evidence-development determinations in long-awaited 1guidelines issued July 12
CMS Offers Two Paths To “Coverage With Evidence” In Revised Guidance
CMS introduces two distinct categories of coverage-with-evidence-development determinations in long-awaited 1guidelines issued July 12